875 related articles for article (PubMed ID: 24687388)
21. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
[TBL] [Abstract][Full Text] [Related]
22. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of renal tubular damage in chronic heart failure.
Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
[TBL] [Abstract][Full Text] [Related]
24. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A
Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970
[TBL] [Abstract][Full Text] [Related]
25. The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP.
Nielsen SE; Rossing K; Hess G; Zdunek D; Jensen BR; Parving HH; Rossing P
Scand J Clin Lab Invest; 2012 Apr; 72(2):137-42. PubMed ID: 22268365
[TBL] [Abstract][Full Text] [Related]
26. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).
Peralta C; Scherzer R; Grunfeld C; Abraham A; Tien P; Devarajan P; Bennett M; Butch A; Anastos K; Cohen M; Nowicki M; Sharma A; Young M; Sarnak M; Parikh C; Shlipak M
HIV Med; 2014 May; 15(5):291-300. PubMed ID: 24313986
[TBL] [Abstract][Full Text] [Related]
27. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study.
Nielsen SE; Hansen HP; Jensen BR; Parving HH; Rossing P
Nephron Clin Pract; 2011; 118(2):c130-5. PubMed ID: 21160226
[TBL] [Abstract][Full Text] [Related]
28. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Bhavsar NA; Köttgen A; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
[TBL] [Abstract][Full Text] [Related]
30. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y
Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
[TBL] [Abstract][Full Text] [Related]
31. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
Lacquaniti A; Donato V; Pintaudi B; Di Vieste G; Chirico V; Buemi A; Di Benedetto A; Arena A; Buemi M
Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
[TBL] [Abstract][Full Text] [Related]
32. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
[TBL] [Abstract][Full Text] [Related]
33. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine.
Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S
Adv Med Sci; 2009; 54(2):221-4. PubMed ID: 19875355
[TBL] [Abstract][Full Text] [Related]
34. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia.
Güneş A; Ece A; Aktar F; Tan İ; Söker M; Karabel D; Balık H; Uluca Ü; Şen V; Yolbaş İ
Med Sci Monit; 2015 Dec; 21():4023-9. PubMed ID: 26697893
[TBL] [Abstract][Full Text] [Related]
35. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.
Krawczeski CD; Goldstein SL; Woo JG; Wang Y; Piyaphanee N; Ma Q; Bennett M; Devarajan P
J Am Coll Cardiol; 2011 Nov; 58(22):2301-9. PubMed ID: 22093507
[TBL] [Abstract][Full Text] [Related]
36. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.
Tramonti G; Kanwar YS
Endocrine; 2013 Jun; 43(3):494-503. PubMed ID: 23086402
[TBL] [Abstract][Full Text] [Related]
37. Urine neutrophil gelatinase-associated lipocalin predicts graft outcome up to 1 year after kidney transplantation.
Choi HM; Park KT; Lee JW; Cho E; Jo SK; Cho WY; Kim HK
Transplant Proc; 2013; 45(1):122-8. PubMed ID: 23267793
[TBL] [Abstract][Full Text] [Related]
38. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
[TBL] [Abstract][Full Text] [Related]
39. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
